© 1985 Oxford University Press
research-article |
Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione
1Department of Environmental Health Sciences, Johns Hopkins University School of Hygiene and Public Health Baltimore, MD 21205
2Department of Immunology and Infectious Diseases, Johns Hopkins University School of Hygiene and Public Health Baltimore, MD 21205
3Department of Environmental Health, Boston University School of Public Health, Boston Boston, MA, 02118, USA
4To whom reprint requests should be sent
The effects of dietary administration of 3,5-di-tert-butyl- 4-hydroxytoluene (BHT), 2(3)-tert-butyl-4-hydroxyanisole (BHA), ethoxyquin (EQ) and 5-(2-pyrizinyl)-4-methyl-1,2- dithiol-3-thione (oltipraz) on aflatoxin B1 (AFB1) - DNA adduct formation in vivo in livers and kidneys of rats were investigated. Male F344 rats were treated with 1 mg/kg AFBI by i.p. administration and nucleic acids isolated 2 h post dosing. Animals were fed a semipurifled diet supplemented with either 0.5% EQ, 0.45% BHT, 0.45% BHA or 0.1% oltipraz for 2 weeks prior to AFBI treatment. Analysis of nucleic acid bases by h.p.l.c. showed that several AFB metabolite-DNA adducts were formed in both tissues. The principal and related adducts of 8,9-dlhydro-8-(N2 guanyl)-9-hydroxyaflatoxin represented 
80-90% of all adducts in both tissues and in all treatment groups. However, inclusion of the antioxidants in the diet resulted in substantial reductions in overall AFB modified DNA levels. EQ, BHT, BHA and oltipraz reduced the covalent binding of AFB to liver DNA by 91, 85, 65 and 76% and to kidney DNA by 80, 35, 62 and 64%, respectively. Concordantly, the specific activities of hepatic enzymes of presumed importance to AFB1 detoxification, epoxide hydrase, and glycuronyl and glutathione transferases were significantly elevated by all antioxidants. Reduced glutathione levels were unchanged except by oltipraz, although activities of enzymes contributing to the maintenance of reduced gluta-thione pools, glutathione reductase and glucose-6- phosphate dehydrogenase, were elevated in most treatment groups. An excellent correlation (r = 0.95) was observed between the degree of inhibition of DNA binding by AFB1 and the induction of hepatic glutathione S-transferase activities by the four antioxidants.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Zhang and R. Munday Dithiolethiones for cancer chemoprevention: where do we stand? Mol. Cancer Ther., November 1, 2008; 7(11): 3470 - 3479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Merrell, J. P. Jackson, L. M. Augustine, C. D. Fisher, A. L. Slitt, J. M. Maher, W. Huang, D. D. Moore, Y. Zhang, C. D. Klaassen, et al. The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane Receptor Drug Metab. Dispos., August 1, 2008; 36(8): 1716 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Yates, M.-K. Kwak, P. A. Egner, J. D. Groopman, S. Bodreddigari, T. R. Sutter, K. J. Baumgartner, B.D. Roebuck, K. T. Liby, M. M. Yore, et al. Potent Protection against Aflatoxin-Induced Tumorigenesis through Induction of Nrf2-Regulated Pathways by the Triterpenoid 1-[2-Cyano-3-,12-Dioxooleana-1,9(11)-Dien-28-Oyl]Imidazole Cancer Res., February 15, 2006; 66(4): 2488 - 2494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Munday and C. M. Munday Induction of phase II enzymes by 3H-1,2-dithiole-3-thione: dose-response study in rats Carcinogenesis, September 1, 2004; 25(9): 1721 - 1725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Roebuck, T. J. Curphey, Y. Li, K. J. Baumgartner, S. Bodreddigari, J. Yan, S. J. Gange, T. W. Kensler, and T. R. Sutter Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz Carcinogenesis, December 1, 2003; 24(12): 1919 - 1928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nakamura, K. Okazaki, A. Nishikawa, F. Furukawa, K.-I. Kasahara, M. Miyauchi, T. Imazawa, K. Uchida, and M. Hirose Enhancing Effects of Oltipraz on the Development of Spontaneous Hepatic Lesions in LEC Rats Toxicol Pathol, February 1, 2002; 30(2): 173 - 177. [Abstract] [PDF]
|
|
|
|
 |
|
 A. B. Benson III, O. I. Olopade, M. J. Ratain, A. Rademaker, S. Mobarhan, L. Stucky-Marshall, S. French, and M. E. Dolan Chronic Daily Low Dose of 4-Methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in Patients with Previously Resected Colon Polyps and First-Degree Female Relatives of Breast Cancer Patients Clin. Cancer Res., October 1, 2000; 6(10): 3870 - 3877. [Abstract] [Full Text]
|
|
|
|
|
|
J. G. Lamb and M. R. Franklin Early Events in the Induction of Rat Hepatic UDP-Glucuronosyltransferases, Glutathione S-Transferase, and Microsomal Epoxide Hydrolase by 1,7-Phenanthroline: Comparison with Oltipraz, tert-Butyl-4-hydroxyanisole, and tert-Butylhydroquinone Drug Metab. Dispos., September 1, 2000; 28(9): 1018 - 1023. [Abstract] [Full Text]
|
|
|
|
|
|
J. D. Groopman and T. W. Kensler The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight? Carcinogenesis, January 1, 1999; 20(1): 1 - 11. [Full Text] [PDF]
|
|